APA (7th ed.) Citation

T, P., E, M., ME, R., E, C., T, P., TP, S., . . . ANA, M. (2024). Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing. NPJ precision oncology, 8(1), 247. https://doi.org/10.1038/s41698-024-00741-4

Chicago Style (17th ed.) Citation

T, Pal, Mundt E, Richardson ME, Chao E, Pesaran T, Slavin TP, Couch FJ, and Monteiro ANA. "Reduced Penetrance BRCA1 and BRCA2 Pathogenic Variants in Clinical Germline Genetic Testing." NPJ Precision Oncology 8, no. 1 (2024): 247. https://doi.org/10.1038/s41698-024-00741-4.

MLA (9th ed.) Citation

T, Pal, et al. "Reduced Penetrance BRCA1 and BRCA2 Pathogenic Variants in Clinical Germline Genetic Testing." NPJ Precision Oncology, vol. 8, no. 1, 2024, p. 247, https://doi.org/10.1038/s41698-024-00741-4.